Patents by Inventor Stephane Olland

Stephane Olland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGF21 MIMETIC ANTIBODIES AND USES THEREOF
    Publication number: 20250388698
    Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: April 30, 2025
    Publication date: December 25, 2025
    Inventors: Regis CEBE, Stephane OLLAND, David Langdon YOWE
  • FGF21 MIMETIC ANTIBODIES AND USES THEREOF
    Publication number: 20230416407
    Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: May 15, 2023
    Publication date: December 28, 2023
    Inventors: Regis CEBE, Stephane OLLAND, David Langdon YOWE
  • FGF21 mimetic antibodies and uses thereof
    Patent number: 11692046
    Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: July 4, 2023
    Assignee: Novartis AG
    Inventors: Regis Cebe, Stephane Olland, David Langdon Yowe
  • FGF21 Mimetic Antibodies and Uses Thereof
    Publication number: 20210171659
    Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: December 18, 2020
    Publication date: June 10, 2021
    Applicant: Novartis AG
    Inventors: Regis Cebe, Stephane Olland, David Langdon Yowe
  • FGF21 mimetic antibodies and uses thereof
    Patent number: 10899844
    Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: January 26, 2021
    Assignee: Novartis AG
    Inventors: Regis Cebe, Stephane Olland, David Langdon Yowe
  • FGF21 MIMETIC ANTIBODIES AND USES THEREOF
    Publication number: 20190040153
    Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: February 6, 2018
    Publication date: February 7, 2019
    Inventors: Regis CEBE, Stephane OLLAND, David Langdon YOWE
  • Structure of protein kinase C theta
    Patent number: 7584087
    Abstract: A three-dimensional structure of human protein kinase C theta (PKC?) can be used in methods of designing an agent that interacts with PKC?. The agent can be an inhibitor of PKC? activity.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: September 1, 2009
    Assignee: Wyeth
    Inventors: Zhang Bao Xu, Stephane Olland, Scott Wolfrom, Karl Malakian, Laura Lin, Mark Stahl, Julie Lee, Lori Fitz, Rita Greco, Divya Chaudhary, William Stuart Somers, Lidia Mosyak
  • Use of proteins and peptides of the TGF-Beta superfamily for purification and therapeutic methods
    Publication number: 20080051340
    Abstract: Members of the TGF-? superfamily and peptide fragments based on member proteins are employed to purify solutions containing member proteins or as therapeutics.
    Type: Application
    Filed: June 1, 2007
    Publication date: February 28, 2008
    Applicant: Wyeth
    Inventors: Zhijian Lu, Wei Liu, Jimin Zhang, Paul Yaworsky, Stephane Olland, Christopher Brown, Emily Sheng-ming Shen
  • AGGRECANASE STRUCTURE
    Publication number: 20070178574
    Abstract: This invention relates to aggrecanase polypeptides and aggrecanase polypeptide/ligand complexes, crystals of aggrecanase and aggrecanase polypeptide/ligand complexes, and related methods and software systems.
    Type: Application
    Filed: August 24, 2006
    Publication date: August 2, 2007
    Applicant: WYETH
    Inventors: Lydia Mosyak, Thomas Rush, Xiaotian Zhong, Thomas McDonagh, Katy Georgiadis, Phaik-Eng Sum, Edward LaVallie, Lisa Collins-Racie, Christopher Corcoran, Ravindra Kumar, Tracy Hebert, Stephane Olland, Stewart Mackie
  • AGGRECANASE STRUCTURE
    Publication number: 20070105207
    Abstract: This invention relates to aggrecanase polypeptides and aggrecanase polypeptide/ligand complexes, crystals of aggrecanase and aggrecanase polypeptide/ligand complexes, and related methods and software systems.
    Type: Application
    Filed: August 24, 2006
    Publication date: May 10, 2007
    Applicant: WYETH
    Inventors: Lydia Mosyak, Thomas Rush, Stephane Olland, Edward LaVallie, Lisa Collins-Racie, Christopher Corcoran, Stewart Mackie
  • Structure of protein kinase C theta
    Publication number: 20060003431
    Abstract: A three-dimensional structure of protein kinase C theta (PKC?) can be used in methods of designing an agent that interacts with PKC?. The agent can be an inhibitor of PKC? activity.
    Type: Application
    Filed: April 6, 2005
    Publication date: January 5, 2006
    Inventors: Zhang Xu, Stephane Olland, Scott Wolfrom, Karl Malakian, Laura Lin, Mark Stahl, Julie Lee, Lori Fitz, Rita Greco, Divya Chaudhary, William Somers, Lidia Mosyak